PDB Short entry for 2F29 HEADER HYDROLASE 15-NOV-05 2F29 TITLE CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 Q116E MUTANT IN COMPLEX TITLE 2 WITH DANA INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: SIALIDASE 2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: NEU2, CYTOSOLIC SIALIDASE, N-ACETYL-ALPHA- NEURAMINIDASE 2; COMPND 5 EC: 3.2.1.18; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PGEX-2T KEYWDS SIALIDASE, NEURAMINIDASE, GANGLIOSIDE, DRUG DESIGN, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR L.M.G.CHAVAS,R.KATO,P.FUSI,C.TRINGALI,B.VENERANDO,G.TETTAMANTI, AUTHOR 2 E.MONTI,S.WAKATSUKI REVDAT 5 25-OCT-23 2F29 1 REMARK REVDAT 4 10-NOV-21 2F29 1 SEQADV HETSYN REVDAT 3 29-JUL-20 2F29 1 REMARK SEQADV SITE REVDAT 2 24-FEB-09 2F29 1 VERSN REVDAT 1 21-NOV-06 2F29 0 JRNL AUTH L.M.G.CHAVAS,R.KATO,P.FUSI,C.TRINGALI,B.VENERANDO, JRNL AUTH 2 G.TETTAMANTI,E.MONTI,S.WAKATSUKI JRNL TITL CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 Q116E MUTANT JRNL TITL 2 IN COMPLEX WITH DANA INHIBITOR JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.92 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.92 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 79.06 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.3 REMARK 3 NUMBER OF REFLECTIONS : 19087 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 980 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5830 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 100 REMARK 3 SOLVENT ATOMS : 75 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.65 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 11.32600 REMARK 3 B22 (A**2) : -19.10600 REMARK 3 B33 (A**2) : 7.78100 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 3.25300 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.445 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 43.96 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : DANA_HEPES_REP.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2F29 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 25-NOV-05. REMARK 100 THE DEPOSITION ID IS D_1000035362. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-NOV-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : AR-NW12A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9744 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19087 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 79.060 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.4 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.10900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 6.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.32500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1SNT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2-METHYL-2,4-PENTANEDIOL, GUANIDINE REMARK 280 HYDROCHLORIDE, 2-DEOXY-2,3-DEHYDRO-N-ACETYLNEURAMINIC ACID, PH REMARK 280 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 78.64500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.99000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 78.64500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 36.99000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL UNIT IS A MONOMER. THERE ARE 2 BIOLOGICAL REMARK 300 UNITS IN THE ASYMMETRIC UNIT (CHAIN A AND CHAIN B) REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 THR A 226 REMARK 465 GLY A 227 REMARK 465 GLU A 228 REMARK 465 SER A 284 REMARK 465 GLY A 285 REMARK 465 PRO A 286 REMARK 465 GLY A 287 REMARK 465 LEU A 378 REMARK 465 PRO A 379 REMARK 465 GLN A 380 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 465 THR B 226 REMARK 465 GLY B 227 REMARK 465 GLU B 228 REMARK 465 SER B 284 REMARK 465 GLY B 285 REMARK 465 PRO B 286 REMARK 465 GLY B 287 REMARK 465 LEU B 378 REMARK 465 PRO B 379 REMARK 465 GLN B 380 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 268 C - N - CA ANGL. DEV. = 11.3 DEGREES REMARK 500 PRO B 268 C - N - CA ANGL. DEV. = 14.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 8 135.25 -172.00 REMARK 500 ILE A 22 72.89 52.32 REMARK 500 GLU A 47 -10.11 -46.12 REMARK 500 GLU A 50 -70.89 -138.47 REMARK 500 ASN A 86 90.26 66.63 REMARK 500 ASP A 131 52.13 -118.13 REMARK 500 ILE A 147 -98.00 -118.46 REMARK 500 CYS A 164 -157.83 -88.05 REMARK 500 ARG A 170 -3.38 -53.89 REMARK 500 ALA A 171 19.15 -146.08 REMARK 500 ARG A 172 79.16 36.44 REMARK 500 ALA A 207 140.91 -175.22 REMARK 500 VAL A 212 -163.03 -113.29 REMARK 500 ASP A 215 44.55 71.88 REMARK 500 LEU A 217 -137.83 -113.87 REMARK 500 ALA A 242 -157.41 -131.08 REMARK 500 GLU A 257 21.92 46.79 REMARK 500 VAL A 265 174.85 -56.84 REMARK 500 PRO A 268 -74.18 -21.77 REMARK 500 PRO A 269 -93.55 -48.61 REMARK 500 ASP A 306 80.36 52.31 REMARK 500 ALA A 333 -138.54 -140.26 REMARK 500 TYR A 334 137.06 -38.90 REMARK 500 GLU A 376 32.54 -69.03 REMARK 500 ILE B 22 67.77 64.15 REMARK 500 GLU B 50 -69.39 -135.48 REMARK 500 ARG B 78 174.16 169.92 REMARK 500 ASP B 80 106.01 -16.85 REMARK 500 ASN B 86 72.33 59.34 REMARK 500 ASP B 131 52.21 -117.27 REMARK 500 HIS B 132 19.04 48.29 REMARK 500 THR B 156 159.06 179.75 REMARK 500 ASN B 168 39.98 -99.44 REMARK 500 PHE B 195 177.32 171.00 REMARK 500 ALA B 213 130.87 -22.59 REMARK 500 GLN B 214 158.02 -31.93 REMARK 500 LEU B 217 -144.16 -105.61 REMARK 500 VAL B 265 178.08 -53.85 REMARK 500 PRO B 268 -58.43 -27.18 REMARK 500 PRO B 269 -88.11 -58.92 REMARK 500 ASP B 306 76.85 56.66 REMARK 500 PRO B 316 48.37 -103.40 REMARK 500 SER B 331 109.74 -46.13 REMARK 500 ALA B 333 -126.80 -126.77 REMARK 500 ASN B 357 76.16 43.98 REMARK 500 GLU B 361 149.68 -179.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1SNT RELATED DB: PDB REMARK 900 HUMAN NEU2 APO-FORM REMARK 900 RELATED ID: 1SO7 RELATED DB: PDB REMARK 900 HUMAN NEU2 SUGAR-INDUCED FORM REMARK 900 RELATED ID: 1VCU RELATED DB: PDB REMARK 900 HUMAN NEU2-DANA COMPLEX REMARK 900 RELATED ID: 2F0Z RELATED DB: PDB REMARK 900 RELATED ID: 2F10 RELATED DB: PDB REMARK 900 RELATED ID: 2F11 RELATED DB: PDB REMARK 900 RELATED ID: 2F12 RELATED DB: PDB REMARK 900 RELATED ID: 2F13 RELATED DB: PDB REMARK 900 RELATED ID: 2F24 RELATED DB: PDB REMARK 900 RELATED ID: 2F25 RELATED DB: PDB REMARK 900 RELATED ID: 2F26 RELATED DB: PDB REMARK 900 RELATED ID: 2F27 RELATED DB: PDB REMARK 900 RELATED ID: 2F28 RELATED DB: PDB DBREF 2F29 A 1 380 UNP Q9Y3R4 NEUR2_HUMAN 1 380 DBREF 2F29 B 1 380 UNP Q9Y3R4 NEUR2_HUMAN 1 380 SEQADV 2F29 GLY A -1 UNP Q9Y3R4 CLONING ARTIFACT SEQADV 2F29 SER A 0 UNP Q9Y3R4 CLONING ARTIFACT SEQADV 2F29 GLU A 116 UNP Q9Y3R4 GLN 116 ENGINEERED MUTATION SEQADV 2F29 GLY B -1 UNP Q9Y3R4 CLONING ARTIFACT SEQADV 2F29 SER B 0 UNP Q9Y3R4 CLONING ARTIFACT SEQADV 2F29 GLU B 116 UNP Q9Y3R4 GLN 116 ENGINEERED MUTATION SEQRES 1 A 382 GLY SER MET ALA SER LEU PRO VAL LEU GLN LYS GLU SER SEQRES 2 A 382 VAL PHE GLN SER GLY ALA HIS ALA TYR ARG ILE PRO ALA SEQRES 3 A 382 LEU LEU TYR LEU PRO GLY GLN GLN SER LEU LEU ALA PHE SEQRES 4 A 382 ALA GLU GLN ARG ALA SER LYS LYS ASP GLU HIS ALA GLU SEQRES 5 A 382 LEU ILE VAL LEU ARG ARG GLY ASP TYR ASP ALA PRO THR SEQRES 6 A 382 HIS GLN VAL GLN TRP GLN ALA GLN GLU VAL VAL ALA GLN SEQRES 7 A 382 ALA ARG LEU ASP GLY HIS ARG SER MET ASN PRO CYS PRO SEQRES 8 A 382 LEU TYR ASP ALA GLN THR GLY THR LEU PHE LEU PHE PHE SEQRES 9 A 382 ILE ALA ILE PRO GLY GLN VAL THR GLU GLN GLN GLN LEU SEQRES 10 A 382 GLU THR ARG ALA ASN VAL THR ARG LEU CYS GLN VAL THR SEQRES 11 A 382 SER THR ASP HIS GLY ARG THR TRP SER SER PRO ARG ASP SEQRES 12 A 382 LEU THR ASP ALA ALA ILE GLY PRO ALA TYR ARG GLU TRP SEQRES 13 A 382 SER THR PHE ALA VAL GLY PRO GLY HIS CYS LEU GLN LEU SEQRES 14 A 382 ASN ASP ARG ALA ARG SER LEU VAL VAL PRO ALA TYR ALA SEQRES 15 A 382 TYR ARG LYS LEU HIS PRO ILE GLN ARG PRO ILE PRO SER SEQRES 16 A 382 ALA PHE CYS PHE LEU SER HIS ASP HIS GLY ARG THR TRP SEQRES 17 A 382 ALA ARG GLY HIS PHE VAL ALA GLN ASP THR LEU GLU CYS SEQRES 18 A 382 GLN VAL ALA GLU VAL GLU THR GLY GLU GLN ARG VAL VAL SEQRES 19 A 382 THR LEU ASN ALA ARG SER HIS LEU ARG ALA ARG VAL GLN SEQRES 20 A 382 ALA GLN SER THR ASN ASP GLY LEU ASP PHE GLN GLU SER SEQRES 21 A 382 GLN LEU VAL LYS LYS LEU VAL GLU PRO PRO PRO GLN GLY SEQRES 22 A 382 CYS GLN GLY SER VAL ILE SER PHE PRO SER PRO ARG SER SEQRES 23 A 382 GLY PRO GLY SER PRO ALA GLN TRP LEU LEU TYR THR HIS SEQRES 24 A 382 PRO THR HIS SER TRP GLN ARG ALA ASP LEU GLY ALA TYR SEQRES 25 A 382 LEU ASN PRO ARG PRO PRO ALA PRO GLU ALA TRP SER GLU SEQRES 26 A 382 PRO VAL LEU LEU ALA LYS GLY SER CYS ALA TYR SER ASP SEQRES 27 A 382 LEU GLN SER MET GLY THR GLY PRO ASP GLY SER PRO LEU SEQRES 28 A 382 PHE GLY CYS LEU TYR GLU ALA ASN ASP TYR GLU GLU ILE SEQRES 29 A 382 VAL PHE LEU MET PHE THR LEU LYS GLN ALA PHE PRO ALA SEQRES 30 A 382 GLU TYR LEU PRO GLN SEQRES 1 B 382 GLY SER MET ALA SER LEU PRO VAL LEU GLN LYS GLU SER SEQRES 2 B 382 VAL PHE GLN SER GLY ALA HIS ALA TYR ARG ILE PRO ALA SEQRES 3 B 382 LEU LEU TYR LEU PRO GLY GLN GLN SER LEU LEU ALA PHE SEQRES 4 B 382 ALA GLU GLN ARG ALA SER LYS LYS ASP GLU HIS ALA GLU SEQRES 5 B 382 LEU ILE VAL LEU ARG ARG GLY ASP TYR ASP ALA PRO THR SEQRES 6 B 382 HIS GLN VAL GLN TRP GLN ALA GLN GLU VAL VAL ALA GLN SEQRES 7 B 382 ALA ARG LEU ASP GLY HIS ARG SER MET ASN PRO CYS PRO SEQRES 8 B 382 LEU TYR ASP ALA GLN THR GLY THR LEU PHE LEU PHE PHE SEQRES 9 B 382 ILE ALA ILE PRO GLY GLN VAL THR GLU GLN GLN GLN LEU SEQRES 10 B 382 GLU THR ARG ALA ASN VAL THR ARG LEU CYS GLN VAL THR SEQRES 11 B 382 SER THR ASP HIS GLY ARG THR TRP SER SER PRO ARG ASP SEQRES 12 B 382 LEU THR ASP ALA ALA ILE GLY PRO ALA TYR ARG GLU TRP SEQRES 13 B 382 SER THR PHE ALA VAL GLY PRO GLY HIS CYS LEU GLN LEU SEQRES 14 B 382 ASN ASP ARG ALA ARG SER LEU VAL VAL PRO ALA TYR ALA SEQRES 15 B 382 TYR ARG LYS LEU HIS PRO ILE GLN ARG PRO ILE PRO SER SEQRES 16 B 382 ALA PHE CYS PHE LEU SER HIS ASP HIS GLY ARG THR TRP SEQRES 17 B 382 ALA ARG GLY HIS PHE VAL ALA GLN ASP THR LEU GLU CYS SEQRES 18 B 382 GLN VAL ALA GLU VAL GLU THR GLY GLU GLN ARG VAL VAL SEQRES 19 B 382 THR LEU ASN ALA ARG SER HIS LEU ARG ALA ARG VAL GLN SEQRES 20 B 382 ALA GLN SER THR ASN ASP GLY LEU ASP PHE GLN GLU SER SEQRES 21 B 382 GLN LEU VAL LYS LYS LEU VAL GLU PRO PRO PRO GLN GLY SEQRES 22 B 382 CYS GLN GLY SER VAL ILE SER PHE PRO SER PRO ARG SER SEQRES 23 B 382 GLY PRO GLY SER PRO ALA GLN TRP LEU LEU TYR THR HIS SEQRES 24 B 382 PRO THR HIS SER TRP GLN ARG ALA ASP LEU GLY ALA TYR SEQRES 25 B 382 LEU ASN PRO ARG PRO PRO ALA PRO GLU ALA TRP SER GLU SEQRES 26 B 382 PRO VAL LEU LEU ALA LYS GLY SER CYS ALA TYR SER ASP SEQRES 27 B 382 LEU GLN SER MET GLY THR GLY PRO ASP GLY SER PRO LEU SEQRES 28 B 382 PHE GLY CYS LEU TYR GLU ALA ASN ASP TYR GLU GLU ILE SEQRES 29 B 382 VAL PHE LEU MET PHE THR LEU LYS GLN ALA PHE PRO ALA SEQRES 30 B 382 GLU TYR LEU PRO GLN HET DAN A 381 20 HET EPE A 382 15 HET EPE A 383 15 HET DAN B 381 20 HET EPE B 382 15 HET EPE B 383 15 HETNAM DAN 2-DEOXY-2,3-DEHYDRO-N-ACETYL-NEURAMINIC ACID HETNAM EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID HETSYN DAN NEU5AC2EN HETSYN EPE HEPES FORMUL 3 DAN 2(C11 H17 N O8) FORMUL 4 EPE 4(C8 H18 N2 O4 S) FORMUL 9 HOH *75(H2 O) HELIX 1 1 LYS A 45 ALA A 49 5 5 HELIX 2 2 THR A 110 THR A 117 1 8 HELIX 3 3 LEU A 142 ILE A 147 1 6 HELIX 4 4 ALA A 317 TRP A 321 5 5 HELIX 5 5 LEU A 369 PHE A 373 1 5 HELIX 6 6 PRO A 374 TYR A 377 5 4 HELIX 7 7 LYS B 45 GLU B 47 5 3 HELIX 8 8 THR B 110 THR B 117 1 8 HELIX 9 9 LEU B 142 ILE B 147 1 6 HELIX 10 10 GLY B 148 ARG B 152 5 5 HELIX 11 11 ALA B 317 TRP B 321 5 5 HELIX 12 12 LEU B 369 PHE B 373 1 5 HELIX 13 13 PRO B 374 TYR B 377 5 4 SHEET 1 A14 SER A 275 PRO A 280 0 SHEET 2 A14 GLN A 291 PRO A 298 -1 O THR A 296 N SER A 275 SHEET 3 A14 ALA A 305 ASN A 312 -1 O GLY A 308 N HIS A 297 SHEET 4 A14 VAL A 325 THR A 342 -1 O LEU A 327 N LEU A 307 SHEET 5 A14 PRO A 348 ALA A 356 -1 O LEU A 349 N GLY A 341 SHEET 6 A14 GLU A 361 THR A 368 -1 O LEU A 365 N CYS A 352 SHEET 7 A14 GLN A 8 GLN A 14 -1 N GLU A 10 O PHE A 364 SHEET 8 A14 GLN B 8 GLN B 14 -1 O LYS B 9 N SER A 11 SHEET 9 A14 GLU B 361 THR B 368 -1 O ILE B 362 N VAL B 12 SHEET 10 A14 PRO B 348 ALA B 356 -1 N CYS B 352 O LEU B 365 SHEET 11 A14 VAL B 325 THR B 342 -1 N GLY B 341 O LEU B 349 SHEET 12 A14 ALA B 305 ASN B 312 -1 N LEU B 307 O LEU B 327 SHEET 13 A14 GLN B 291 PRO B 298 -1 N HIS B 297 O GLY B 308 SHEET 14 A14 SER B 275 PRO B 280 -1 N SER B 275 O THR B 296 SHEET 1 B 4 ALA A 19 TYR A 27 0 SHEET 2 B 4 SER A 33 ARG A 41 -1 O GLU A 39 N ARG A 21 SHEET 3 B 4 LEU A 51 ASP A 60 -1 O LEU A 51 N GLN A 40 SHEET 4 B 4 GLN A 65 TRP A 68 -1 O GLN A 65 N ASP A 60 SHEET 1 C 4 ALA A 19 TYR A 27 0 SHEET 2 C 4 SER A 33 ARG A 41 -1 O GLU A 39 N ARG A 21 SHEET 3 C 4 LEU A 51 ASP A 60 -1 O LEU A 51 N GLN A 40 SHEET 4 C 4 GLU A 72 VAL A 73 -1 O GLU A 72 N LEU A 54 SHEET 1 D 4 HIS A 82 ASP A 92 0 SHEET 2 D 4 THR A 97 PRO A 106 -1 O PHE A 99 N LEU A 90 SHEET 3 D 4 ARG A 123 SER A 129 -1 O SER A 129 N LEU A 98 SHEET 4 D 4 ARG A 140 ASP A 141 -1 O ARG A 140 N GLN A 126 SHEET 1 E 3 TRP A 154 VAL A 159 0 SHEET 2 E 3 LEU A 174 ARG A 182 -1 O TYR A 181 N SER A 155 SHEET 3 E 3 LEU A 165 GLN A 166 -1 N LEU A 165 O VAL A 175 SHEET 1 F 3 TRP A 154 VAL A 159 0 SHEET 2 F 3 LEU A 174 ARG A 182 -1 O TYR A 181 N SER A 155 SHEET 3 F 3 ILE A 191 SER A 199 -1 O PHE A 195 N ALA A 178 SHEET 1 G 4 THR A 216 VAL A 224 0 SHEET 2 G 4 VAL A 231 SER A 238 -1 O ARG A 237 N LEU A 217 SHEET 3 G 4 ALA A 242 SER A 248 -1 O ALA A 246 N LEU A 234 SHEET 4 G 4 GLN A 256 VAL A 265 -1 O GLN A 256 N GLN A 247 SHEET 1 H 4 ALA B 19 TYR B 27 0 SHEET 2 H 4 SER B 33 ARG B 41 -1 O ARG B 41 N ALA B 19 SHEET 3 H 4 ALA B 49 ASP B 60 -1 O LEU B 51 N GLN B 40 SHEET 4 H 4 GLN B 65 TRP B 68 -1 O GLN B 65 N ASP B 60 SHEET 1 I 4 ALA B 19 TYR B 27 0 SHEET 2 I 4 SER B 33 ARG B 41 -1 O ARG B 41 N ALA B 19 SHEET 3 I 4 ALA B 49 ASP B 60 -1 O LEU B 51 N GLN B 40 SHEET 4 I 4 GLU B 72 VAL B 73 -1 O GLU B 72 N LEU B 54 SHEET 1 J 4 HIS B 82 TYR B 91 0 SHEET 2 J 4 LEU B 98 PRO B 106 -1 O ILE B 105 N ARG B 83 SHEET 3 J 4 ARG B 123 SER B 129 -1 O SER B 129 N LEU B 98 SHEET 4 J 4 ARG B 140 ASP B 141 -1 O ARG B 140 N GLN B 126 SHEET 1 K 3 TRP B 154 VAL B 159 0 SHEET 2 K 3 LEU B 174 ARG B 182 -1 O TYR B 181 N THR B 156 SHEET 3 K 3 LEU B 165 GLN B 166 -1 N LEU B 165 O VAL B 175 SHEET 1 L 3 TRP B 154 VAL B 159 0 SHEET 2 L 3 LEU B 174 ARG B 182 -1 O TYR B 181 N THR B 156 SHEET 3 L 3 ILE B 191 SER B 199 -1 O PHE B 195 N ALA B 178 SHEET 1 M 4 VAL B 221 VAL B 224 0 SHEET 2 M 4 VAL B 231 ALA B 236 -1 O VAL B 231 N VAL B 224 SHEET 3 M 4 ALA B 242 SER B 248 -1 O ALA B 246 N LEU B 234 SHEET 4 M 4 GLU B 257 VAL B 265 -1 O GLN B 259 N GLN B 245 CISPEP 1 GLY A 160 PRO A 161 0 0.05 CISPEP 2 PRO A 315 PRO A 316 0 -0.10 CISPEP 3 GLY B 160 PRO B 161 0 0.07 CISPEP 4 PRO B 315 PRO B 316 0 0.11 CRYST1 157.290 73.980 77.180 90.00 93.14 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006358 0.000000 0.000349 0.00000 SCALE2 0.000000 0.013517 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012976 0.00000